Home › Trial NCT06483282
A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer
- Trial IDNCT06483282
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorJin Ying
- Enrollment38
- Start date2024-06-21
- ConditionsSmall Cell Lung Cancer Limited Stage
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.